Boxer Capital, LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$1,452,220
+14172.4%
506,000
-74.9%
0.08%
-83.7%
Q2 2023$10,175
+167.2%
2,014,8580.0%0.47%
+152.4%
Q1 2023$3,808
-99.9%
2,014,8580.0%0.19%
-2.1%
Q4 2022$3,626,744
+6.5%
2,014,8580.0%0.19%0.0%
Q3 2022$3,405,000
-31.3%
2,014,8580.0%0.19%
-39.2%
Q2 2022$4,957,000
-11.2%
2,014,8580.0%0.31%
+9.4%
Q1 2022$5,581,000
-48.0%
2,014,8580.0%0.29%
-31.2%
Q4 2021$10,739,000
-37.0%
2,014,8580.0%0.42%
-29.9%
Q3 2021$17,046,000
-30.6%
2,014,8580.0%0.60%
-31.4%
Q2 2021$24,561,000
-49.8%
2,014,8580.0%0.87%
-47.7%
Q1 2021$48,880,000
-24.3%
2,014,8580.0%1.66%
-20.1%
Q4 2020$64,576,000
+6.0%
2,014,8580.0%2.08%
-1.4%
Q3 2020$60,909,000
-28.3%
2,014,8580.0%2.10%
-43.6%
Q2 2020$84,946,000
+69.0%
2,014,8580.0%3.74%
+9.0%
Q1 2020$50,271,0002,014,8583.43%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$104,289,0004.42%
Boxer Capital, LLC 2,014,858$60,909,0002.10%
RA Capital Management 2,589,904$78,293,0001.43%
Artal Group S.A. 1,521,517$45,995,0001.12%
Ikarian Capital, LLC 358,941$10,851,0000.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$24,260,0000.59%
Bellevue Group AG 1,403,000$42,413,0000.59%
Logos Global Management LP 123,465$3,732,0000.48%
Casdin Capital, LLC 289,395$8,748,0000.39%
HighVista Strategies LLC 16,391$496,0000.36%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders